Kirchengast M, Raschack M
Department of Cardiovascular Pharmacology, Ludwigshafen, F.R.G.
Eur J Pharmacol. 1989 Feb 7;160(3):349-58. doi: 10.1016/0014-2999(89)90090-3.
K+ release into the extracellular space was investigated during repeated 6-min coronary occlusions before and after the intravenous administration of cardiovascular active doses of gallopamil (0.02; 0.05 mg/kg), diltiazem (1.0; 2.0 mg/kg) or nifedipine (0.01; 0.05 mg/kg) to anaesthetized pigs. [K+]e was measured epicardially using silver valinomycin electrodes calibrated in vivo. During control occlusions [K+]e- rose steeply in all groups, from a pre-ischaemic baseline value of about 3.5 mmol/l reaching a plateau value within the ischaemic period. This response was reproducible in an untreated control group. Gallopamil reduced the ischaemic K+ efflux dose dependently and significantly 10 min after injection; the higher dose also did 60 min after injection. Diltiazem had less effect on K+ efflux 10 min after administration and an effect was no longer detectable after 60 min. Nifedipine did not significantly inhibit the ischaemic K+ loss. Besides these differences in the direct protection of the ischaemic myocardium, the Ca2+ antagonists also had the following effects on the haemodynamic profile. Diltiazem and gallopamil significantly prolonged PQ intervals whereas nifedipine caused a shortening accompanied by a significant increase in heart rate. Blood pressure and LV dP/dtmax were significantly reduced by all compounds, but to a different degree. Diltiazem reduced blood pressure to a greater extent than did nifedipine and gallopamil. LV dP/dtmax was comparably reduced by gallopamil and diltiazem, while nifedipine had less effect. Thus, gallopamil exerted pronounced protective effects on the ischaemic pig heart.
在给麻醉猪静脉注射心血管活性剂量的加洛帕米(0.02;0.05mg/kg)、地尔硫䓬(1.0;2.0mg/kg)或硝苯地平(0.01;0.05mg/kg)之前和之后,在重复6分钟冠状动脉闭塞期间研究了钾离子(K+)释放到细胞外空间的情况。使用在体内校准的银缬氨霉素电极在心外膜测量[K+]e。在对照闭塞期间,所有组的[K+]e均从缺血前约3.5mmol/l的基线值急剧上升,在缺血期内达到平台值。这种反应在未治疗的对照组中是可重复的。加洛帕米在注射后10分钟剂量依赖性且显著地降低了缺血性K+外流;较高剂量在注射后60分钟时也有此作用。地尔硫䓬在给药后10分钟对K+外流的影响较小,60分钟后不再能检测到其作用。硝苯地平未显著抑制缺血性K+丢失。除了在直接保护缺血心肌方面存在这些差异外,钙拮抗剂对血流动力学参数也有以下影响。地尔硫䓬和加洛帕米显著延长PQ间期,而硝苯地平则导致PQ间期缩短并伴有心率显著增加。所有化合物均显著降低血压和左心室dp/dtmax,但程度不同。地尔硫䓬比硝苯地平和加洛帕米更能降低血压。加洛帕米和地尔硫䓬对左心室dp/dtmax的降低程度相当,而硝苯地平的作用较小。因此,加洛帕米对缺血猪心脏具有显著的保护作用。